{"id":17035,"date":"2019-12-02T12:25:56","date_gmt":"2019-12-02T12:25:56","guid":{"rendered":"https:\/\/www.elza-institute.com\/?p=17035"},"modified":"2020-11-20T15:04:32","modified_gmt":"2020-11-20T15:04:32","slug":"nanotechnology-treatment-graves-disease","status":"publish","type":"post","link":"https:\/\/www.elza-institute.com\/pt\/nanotechnology-treatment-graves-disease\/","title":{"rendered":"Nanotecnologia no tratamento da doen\u00e7a ocular de Graves"},"content":{"rendered":"<p><strong>Poder do p\u00f3dio:\u00a0<span class=\"s1\">Dion Paridaens d\u00e1 a palestra principal do EUGOGO: Nanotecnologia no tratamento de doen\u00e7as oculares<\/span><\/strong><\/p>\n<p class=\"p1\"><span class=\"s1\">No s\u00e1bado, 9 de novembro, o cirurgi\u00e3o oculopl\u00e1stico e orbital consultor da ELZA, Dr. Dion Paridaens, foi convidado pelos organizadores da 20\u00aa reuni\u00e3o do Grupo Europeu de Orbitopatia de Graves (EUGOGO) para dar uma Palestra Principal no \u00faltimo dia da confer\u00eancia, que se realizou na cidade italiana de Pisa, sobre o tema da Nanotecnologia no Tratamento de Doen\u00e7as Oculares. A reuni\u00e3o de tr\u00eas dias contou com a presen\u00e7a de muitos dos melhores investigadores, oftalmologistas e endocrinologistas do mundo na \u00e1rea das doen\u00e7as oculares de Graves, e a palestra do Dr. Paridaens foi o \"ato principal\" do \u00faltimo dia da confer\u00eancia.<\/span><!--more--><\/p>\n<figure id=\"attachment_16954\" aria-describedby=\"caption-attachment-16954\" style=\"width: 290px\" class=\"wp-caption alignleft\"><a href=\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2019\/11\/Nanocort-molecule.png\"><img fetchpriority=\"high\" decoding=\"async\" class=\"wp-image-16954 size-medium\" src=\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2019\/11\/Nanocort-molecule-290x300.png\" alt=\"\" width=\"290\" height=\"300\" srcset=\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2019\/11\/Nanocort-molecule-290x300.png 290w, https:\/\/www.elza-institute.com\/wp-content\/uploads\/2019\/11\/Nanocort-molecule.png 392w\" sizes=\"(max-width: 290px) 100vw, 290px\" \/><\/a><figcaption id=\"caption-attachment-16954\" class=\"wp-caption-text\"><em>Figura 1. Nanocort \"lipossomas\" que cont\u00eam o medicamento prednisolona, numa part\u00edcula com menos de 100 nan\u00f3metros de di\u00e2metro<\/em>.<\/figcaption><\/figure>\n<p class=\"p1\"><span class=\"s1\">O Dr. Paridaens ocupa cargos no Rotterdam Eye Hospital e no Erasmus Medical Centre, onde existe um centro de investiga\u00e7\u00e3o orbital muito ativo que investiga tudo, desde as causas desta doen\u00e7a at\u00e9 \u00e0 melhoria e desenvolvimento de novos tratamentos para esta doen\u00e7a complexa e muitas vezes altamente debilitante, que pode levar a olhos esbugalhados, vis\u00e3o dupla e at\u00e9 cegueira. <\/span><\/p>\n<p class=\"p1\"><span class=\"s1\">Como \u00e9 que isto se relaciona com a utiliza\u00e7\u00e3o da nanotecnologia no tratamento da doen\u00e7a ocular de Graves? Paridaens relatou um estudo cl\u00ednico realizado num pequeno grupo de doentes com Orbitopatia de Graves a quem foi administrado Nanocort, uma formula\u00e7\u00e3o de nanopart\u00edculas do esteroide prednisolona, para tratar os sintomas inflamat\u00f3rios desta doen\u00e7a. O Nanocort cont\u00e9m part\u00edculas incrivelmente pequenas (100 nm) (conhecidas como \"ves\u00edculas\" - Figura 1) que s\u00e3o embaladas com o esteroide no seu interior, sendo o medicamento infundido no organismo por via intravenosa. A ideia subjacente a esta abordagem \u00e9 que as mol\u00e9culas do f\u00e1rmaco devem ter como alvo os locais de inflama\u00e7\u00e3o e n\u00e3o os locais \"fora do alvo\", que podem causar efeitos secund\u00e1rios. <\/span><\/p>\n<p class=\"p1\"><span class=\"s1\">Roterd\u00e3o foi o primeiro centro no mundo a avaliar o Nanocort para este tratamento, e este estudo piloto mostrou que muitos dos doentes com Orbitopatia de Graves que participaram neste ensaio experimentaram um tratamento eficaz da sua inflama\u00e7\u00e3o, sem os efeitos secund\u00e1rios que a medica\u00e7\u00e3o regular (metil prednisolona) normalmente causa. Este in\u00edcio promissor significa que \u00e9 prov\u00e1vel que se realizem mais estudos, com mais doentes, e que comparem diretamente o Nanocort com a metilprednisolona num futuro pr\u00f3ximo.<\/span><\/p>","protected":false},"excerpt":{"rendered":"<p>Poder do p\u00f3dio: Dion Paridaens d\u00e1 a palestra principal do EUGOGO: A nanotecnologia no tratamento das doen\u00e7as oculares...<\/p>","protected":false},"author":4,"featured_media":17038,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[244,97],"tags":[299,349,348,347,206,283,284,285],"class_list":["post-17035","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-dion-paridaens","category-podium-power","tag-dion-paridaens","tag-eugogo","tag-graves-eye-disease","tag-nanotechnology","tag-oculoplastics","tag-ophthalmology","tag-podium","tag-research"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nanotechnology in the treatment of Graves\u2019 eye disease - Dion Paridaens<\/title>\n<meta name=\"description\" content=\"Dr. Dion Paridaens gave the keynote lecture on the last day of the EUGOGO congress, on the topic of &quot;Nanotechnology in the treatment of Graves&#039; eye disease&quot;\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.elza-institute.com\/pt\/dion-paridaens-nanotechnologie-behandlung-morbus-basedow-augenerkrankung\/\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanotechnology in the treatment of Graves\u2019 eye disease - Dion Paridaens\" \/>\n<meta property=\"og:description\" content=\"Dr. Dion Paridaens gave the keynote lecture on the last day of the EUGOGO congress, on the topic of &quot;Nanotechnology in the treatment of Graves&#039; eye disease&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.elza-institute.com\/pt\/dion-paridaens-nanotechnologie-behandlung-morbus-basedow-augenerkrankung\/\" \/>\n<meta property=\"og:site_name\" content=\"The ELZA Institute\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ELZA.Institute\/\" \/>\n<meta property=\"article:published_time\" content=\"2019-12-02T12:25:56+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-11-20T15:04:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2019\/12\/Featured-Image-Dion-Paridaens-Pisa.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Mark Hillen\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mark Hillen\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.elza-institute.com\/de-ch\/dion-paridaens-nanotechnologie-behandlung-morbus-basedow-augenerkrankung\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.elza-institute.com\/de-ch\/dion-paridaens-nanotechnologie-behandlung-morbus-basedow-augenerkrankung\/\"},\"author\":{\"name\":\"Mark Hillen\",\"@id\":\"https:\/\/www.elza-institute.com\/#\/schema\/person\/e3929262886a5a60dd6965a6bc721d15\"},\"headline\":\"Nanotechnology in the treatment of Graves\u2019 eye disease\",\"datePublished\":\"2019-12-02T12:25:56+00:00\",\"dateModified\":\"2020-11-20T15:04:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.elza-institute.com\/de-ch\/dion-paridaens-nanotechnologie-behandlung-morbus-basedow-augenerkrankung\/\"},\"wordCount\":383,\"publisher\":{\"@id\":\"https:\/\/www.elza-institute.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.elza-institute.com\/de-ch\/dion-paridaens-nanotechnologie-behandlung-morbus-basedow-augenerkrankung\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2019\/12\/Featured-Image-Dion-Paridaens-Pisa.jpg\",\"keywords\":[\"Dion Paridaens\",\"EUGOGO\",\"Graves\u2019 eye Disease\",\"nanotechnology\",\"Oculoplastics\",\"ophthalmology\",\"podium\",\"research\"],\"articleSection\":[\"Dion Paridaens\",\"Podium Power\"],\"inLanguage\":\"pt-PT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.elza-institute.com\/de-ch\/dion-paridaens-nanotechnologie-behandlung-morbus-basedow-augenerkrankung\/\",\"url\":\"https:\/\/www.elza-institute.com\/de-ch\/dion-paridaens-nanotechnologie-behandlung-morbus-basedow-augenerkrankung\/\",\"name\":\"Nanotechnology in the treatment of Graves\u2019 eye disease - Dion Paridaens\",\"isPartOf\":{\"@id\":\"https:\/\/www.elza-institute.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.elza-institute.com\/de-ch\/dion-paridaens-nanotechnologie-behandlung-morbus-basedow-augenerkrankung\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.elza-institute.com\/de-ch\/dion-paridaens-nanotechnologie-behandlung-morbus-basedow-augenerkrankung\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2019\/12\/Featured-Image-Dion-Paridaens-Pisa.jpg\",\"datePublished\":\"2019-12-02T12:25:56+00:00\",\"dateModified\":\"2020-11-20T15:04:32+00:00\",\"description\":\"Dr. Dion Paridaens gave the keynote lecture on the last day of the EUGOGO congress, on the topic of \\\"Nanotechnology in the treatment of Graves' eye disease\\\"\",\"breadcrumb\":{\"@id\":\"https:\/\/www.elza-institute.com\/de-ch\/dion-paridaens-nanotechnologie-behandlung-morbus-basedow-augenerkrankung\/#breadcrumb\"},\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.elza-institute.com\/de-ch\/dion-paridaens-nanotechnologie-behandlung-morbus-basedow-augenerkrankung\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\/\/www.elza-institute.com\/de-ch\/dion-paridaens-nanotechnologie-behandlung-morbus-basedow-augenerkrankung\/#primaryimage\",\"url\":\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2019\/12\/Featured-Image-Dion-Paridaens-Pisa.jpg\",\"contentUrl\":\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2019\/12\/Featured-Image-Dion-Paridaens-Pisa.jpg\",\"width\":1200,\"height\":600,\"caption\":\"Featured-Image-Dion-Paridaens-Pisa- Nanotechnology in the treatment of Graves\u2019 eye disease\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.elza-institute.com\/de-ch\/dion-paridaens-nanotechnologie-behandlung-morbus-basedow-augenerkrankung\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.elza-institute.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dion Paridaens\",\"item\":\"https:\/\/www.elza-institute.com\/de-ch\/dion-paridaens\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Nanotechnology in the treatment of Graves\u2019 eye disease\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.elza-institute.com\/#website\",\"url\":\"https:\/\/www.elza-institute.com\/\",\"name\":\"The ELZA Institute\",\"description\":\"Swiss EyeCare at its finest\",\"publisher\":{\"@id\":\"https:\/\/www.elza-institute.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.elza-institute.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-PT\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.elza-institute.com\/#organization\",\"name\":\"The ELZA Institute\",\"url\":\"https:\/\/www.elza-institute.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\/\/www.elza-institute.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2016\/04\/ELZA-logo-V4.jpg\",\"contentUrl\":\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2016\/04\/ELZA-logo-V4.jpg\",\"width\":1181,\"height\":453,\"caption\":\"The ELZA Institute\"},\"image\":{\"@id\":\"https:\/\/www.elza-institute.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/ELZA.Institute\/\",\"https:\/\/x.com\/ELZA_Institute\",\"https:\/\/www.linkedin.com\/company\/elza-institute?trk=top_nav_home\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.elza-institute.com\/#\/schema\/person\/e3929262886a5a60dd6965a6bc721d15\",\"name\":\"Mark Hillen\",\"url\":\"https:\/\/www.elza-institute.com\/pt\/author\/markhillen\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nanotecnologia no tratamento da doen\u00e7a ocular de Graves - Dion Paridaens","description":"O Dr. Dion Paridaens proferiu a palestra principal no \u00faltimo dia do congresso EUGOGO, sobre o tema \"Nanotecnologia no tratamento da doen\u00e7a ocular de Graves\"","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.elza-institute.com\/pt\/dion-paridaens-nanotechnologie-behandlung-morbus-basedow-augenerkrankung\/","og_locale":"pt_PT","og_type":"article","og_title":"Nanotechnology in the treatment of Graves\u2019 eye disease - Dion Paridaens","og_description":"Dr. Dion Paridaens gave the keynote lecture on the last day of the EUGOGO congress, on the topic of \"Nanotechnology in the treatment of Graves' eye disease\"","og_url":"https:\/\/www.elza-institute.com\/pt\/dion-paridaens-nanotechnologie-behandlung-morbus-basedow-augenerkrankung\/","og_site_name":"The ELZA Institute","article_publisher":"https:\/\/www.facebook.com\/ELZA.Institute\/","article_published_time":"2019-12-02T12:25:56+00:00","article_modified_time":"2020-11-20T15:04:32+00:00","og_image":[{"width":1200,"height":600,"url":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2019\/12\/Featured-Image-Dion-Paridaens-Pisa.jpg","type":"image\/jpeg"}],"author":"Mark Hillen","twitter_misc":{"Escrito por":"Mark Hillen","Tempo estimado de leitura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.elza-institute.com\/de-ch\/dion-paridaens-nanotechnologie-behandlung-morbus-basedow-augenerkrankung\/#article","isPartOf":{"@id":"https:\/\/www.elza-institute.com\/de-ch\/dion-paridaens-nanotechnologie-behandlung-morbus-basedow-augenerkrankung\/"},"author":{"name":"Mark Hillen","@id":"https:\/\/www.elza-institute.com\/#\/schema\/person\/e3929262886a5a60dd6965a6bc721d15"},"headline":"Nanotechnology in the treatment of Graves\u2019 eye disease","datePublished":"2019-12-02T12:25:56+00:00","dateModified":"2020-11-20T15:04:32+00:00","mainEntityOfPage":{"@id":"https:\/\/www.elza-institute.com\/de-ch\/dion-paridaens-nanotechnologie-behandlung-morbus-basedow-augenerkrankung\/"},"wordCount":383,"publisher":{"@id":"https:\/\/www.elza-institute.com\/#organization"},"image":{"@id":"https:\/\/www.elza-institute.com\/de-ch\/dion-paridaens-nanotechnologie-behandlung-morbus-basedow-augenerkrankung\/#primaryimage"},"thumbnailUrl":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2019\/12\/Featured-Image-Dion-Paridaens-Pisa.jpg","keywords":["Dion Paridaens","EUGOGO","Graves\u2019 eye Disease","nanotechnology","Oculoplastics","ophthalmology","podium","research"],"articleSection":["Dion Paridaens","Podium Power"],"inLanguage":"pt-PT"},{"@type":"WebPage","@id":"https:\/\/www.elza-institute.com\/de-ch\/dion-paridaens-nanotechnologie-behandlung-morbus-basedow-augenerkrankung\/","url":"https:\/\/www.elza-institute.com\/de-ch\/dion-paridaens-nanotechnologie-behandlung-morbus-basedow-augenerkrankung\/","name":"Nanotecnologia no tratamento da doen\u00e7a ocular de Graves - Dion Paridaens","isPartOf":{"@id":"https:\/\/www.elza-institute.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.elza-institute.com\/de-ch\/dion-paridaens-nanotechnologie-behandlung-morbus-basedow-augenerkrankung\/#primaryimage"},"image":{"@id":"https:\/\/www.elza-institute.com\/de-ch\/dion-paridaens-nanotechnologie-behandlung-morbus-basedow-augenerkrankung\/#primaryimage"},"thumbnailUrl":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2019\/12\/Featured-Image-Dion-Paridaens-Pisa.jpg","datePublished":"2019-12-02T12:25:56+00:00","dateModified":"2020-11-20T15:04:32+00:00","description":"O Dr. Dion Paridaens proferiu a palestra principal no \u00faltimo dia do congresso EUGOGO, sobre o tema \"Nanotecnologia no tratamento da doen\u00e7a ocular de Graves\"","breadcrumb":{"@id":"https:\/\/www.elza-institute.com\/de-ch\/dion-paridaens-nanotechnologie-behandlung-morbus-basedow-augenerkrankung\/#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.elza-institute.com\/de-ch\/dion-paridaens-nanotechnologie-behandlung-morbus-basedow-augenerkrankung\/"]}]},{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/www.elza-institute.com\/de-ch\/dion-paridaens-nanotechnologie-behandlung-morbus-basedow-augenerkrankung\/#primaryimage","url":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2019\/12\/Featured-Image-Dion-Paridaens-Pisa.jpg","contentUrl":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2019\/12\/Featured-Image-Dion-Paridaens-Pisa.jpg","width":1200,"height":600,"caption":"Featured-Image-Dion-Paridaens-Pisa- Nanotechnology in the treatment of Graves\u2019 eye disease"},{"@type":"BreadcrumbList","@id":"https:\/\/www.elza-institute.com\/de-ch\/dion-paridaens-nanotechnologie-behandlung-morbus-basedow-augenerkrankung\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.elza-institute.com\/"},{"@type":"ListItem","position":2,"name":"Dion Paridaens","item":"https:\/\/www.elza-institute.com\/de-ch\/dion-paridaens\/"},{"@type":"ListItem","position":3,"name":"Nanotechnology in the treatment of Graves\u2019 eye disease"}]},{"@type":"WebSite","@id":"https:\/\/www.elza-institute.com\/#website","url":"https:\/\/www.elza-institute.com\/","name":"O Instituto ELZA","description":"Swiss EyeCare no seu melhor","publisher":{"@id":"https:\/\/www.elza-institute.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.elza-institute.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-PT"},{"@type":"Organization","@id":"https:\/\/www.elza-institute.com\/#organization","name":"O Instituto ELZA","url":"https:\/\/www.elza-institute.com\/","logo":{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/www.elza-institute.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2016\/04\/ELZA-logo-V4.jpg","contentUrl":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2016\/04\/ELZA-logo-V4.jpg","width":1181,"height":453,"caption":"The ELZA Institute"},"image":{"@id":"https:\/\/www.elza-institute.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ELZA.Institute\/","https:\/\/x.com\/ELZA_Institute","https:\/\/www.linkedin.com\/company\/elza-institute?trk=top_nav_home"]},{"@type":"Person","@id":"https:\/\/www.elza-institute.com\/#\/schema\/person\/e3929262886a5a60dd6965a6bc721d15","name":"Mark Hillen","url":"https:\/\/www.elza-institute.com\/pt\/author\/markhillen\/"}]}},"_links":{"self":[{"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/posts\/17035","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/comments?post=17035"}],"version-history":[{"count":0,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/posts\/17035\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/media\/17038"}],"wp:attachment":[{"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/media?parent=17035"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/categories?post=17035"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/tags?post=17035"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}